MDT
97.97
-0.41%↓
VEEV
301.82
-1.22%↓
A
141.04
+1.79%↑
HQY
92.06
+4.03%↑
PHR.US
23.23
-0.43%↓
MDT
97.97
-0.41%↓
VEEV
301.82
-1.22%↓
A
141.04
+1.79%↑
HQY
92.06
+4.03%↑
PHR.US
23.23
-0.43%↓
MDT
97.97
-0.41%↓
VEEV
301.82
-1.22%↓
A
141.04
+1.79%↑
HQY
92.06
+4.03%↑
PHR.US
23.23
-0.43%↓
MDT
97.97
-0.41%↓
VEEV
301.82
-1.22%↓
A
141.04
+1.79%↑
HQY
92.06
+4.03%↑
PHR.US
23.23
-0.43%↓
MDT
97.97
-0.41%↓
VEEV
301.82
-1.22%↓
A
141.04
+1.79%↑
HQY
92.06
+4.03%↑
PHR.US
23.23
-0.43%↓
24h
Current
Min
2.87
Max
3.04
Recommendations | Buy |
---|---|
12 Months Forecast | +375.41% upside |
Next Earnings | 12 lis 2025 |
---|
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
1 paź 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Read
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Read
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Read
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Read
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Read
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Read
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 14.5 USD 375.41%
High 17 USD
Low 12 USD
Based on 2 Wall Street analysts offering 12 month price targets forFortress Biotech Inc - Dist in the last 3 months.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Based on 2 analysts giving stock ratings to Fortress Biotech Inc - Dist in the past 3 months.
$